|
|
|
||
|
Top Stories 27th
Annual Convention (7/25/08)
Convention
Lecture Legislation Journal
of the American Naturopathic Medical Association (JANMA) Facts |
ANMA ONLINE REFERENCES
Nutrition For Special Needs Children By: Robert J. Thiel, Ph.D., Naturopath
REFERENCES [1] Feingold BF. Hyperkinesis and learning disabilities linked to the ingestion of artificial foods and fats. J Learn Disabil 1976;9(9):551-559 [2] Thiel RJ. Nutrition-based interventions for attention-deficit disorder and attention-deficit hyperactive disorder. Townsend Letter for Doctors and Patients 2000;201:93-96 [3] Werbach MR. Attention-deficit hyperactive disorder. In Textbook of Nutritional Medicine. Third Line Press, Tarzana (CA), 1999:153-162 [4] Pfeiffer CC. Mental and Elemental Nutrients: A Physician’s Guide to Nutrition and Health Care. Keats, New Canaan (CT), 1975 [5] Kanarek RB. Does sucrose or aspartame cause hyperactivity in children. Nutr Rev 1994;52(5):173-175 [6] Kaplan BJ, McNicol J, Conte RA, Moghadam PK. Overall nutrient intake of preschool hyperactive and normal boys. J Abnorm Pyschol 1989;17(2):127-132 [7] McAnalley B. A solid scientific foundation. Breakthrough 2(1):5-7, 1997 [8] Murray RK, Granner DK, Mayes PA, Rodwell VW. Harper’s Biochemistry. Appleton and Lange, Stamford (CN), 1996 [9] Dykman KD, Dykman RA. Effect of nutritional supplementation on attention-deficit hyperactivity disorder. Integr Physiol Behav Sci 1998;33(1):49-60 [10] Axford J. Glycobiology and medicine: an introduction. J R Soc Med,1997;90:260-264 [11] Horrocks LA, Yeo YK. Health benefits of docosahexaenoic acid. Pharmacol Res 1999;40(3):211-225 [12] Wood J, et al. Is docosahexaenoic acid necessary in infant formula? Pediat Res 1996;40(5):687-693 [13] Agostoni C, Carratu B, Boniglia C, Riva E, Sanzini E. Free amino acid content in standard infant formula: comparison with human milk. J Am Coll Nutr, 2000;19(4):434-438 [14] Null G. Complete Encyclopedia of Natural Healing. Kensington Books, New York, 1998 [15] Werbach MR. Autism. In Textbook of Nutritional Medicine. Third Line Press, Tarzana (CA), 1999:163-166 [16] Ratner RS. Vitamin B6, Magnesium, DMG. Autism Res Rev Intl 1998;12(2):6-7 [17] Rimland B. What is the right ‘dosage’ for vitamin B6, DMG, and other nutrients useful in autism? Autism Res Rev Intl 1997;11(4):3 [18] Rimland B. Vitamin C in the prevention and treatment of Autism. Autism Res Rev Intl 1998;12(2):3 [19] Bregman JD, et al. Fragile X syndrome: variability of phenotypic expression. J Am Acad Child Adoles Psychiat 1987;26:463-471 [20] Lelord G, et al. Clinical and biological effects of high dosage vitamin B6 and magnesium in autistic children. Acta Vitaminol Enzymol 1982;4(1-2):27-44 [21] Golf SW, et al. On the significance of magnesium under extreme physical stress. Cardiovasc Drugs Ther 1998;12:197-202 [22] Leklem JE. Vitamin B6. In Modern Nutrition in Health and Disease, 9th ed. Williams & Wilkins, Balt., 1999:413-421 [23] McDougle CJ, et al. Effects of tyrptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiat 1996;53:993-1000 [24] Laryea MD, Steinhagen F, Pawliczek S, Wendel U. Simple method for the routine determination of betaine and N,N-dimethylglycine in blood and urine. Clin Chem,1998;44(9):1937-1941 [25] Kendall RV, Lawson JW. Recent findings on N,N-dimethylglycine (DMG): a nutrient for the new millenium. Townsend Letter,2000;202:75-85 [26] Pugaczewski RM. TMG Announcement. International Nutrition, Inc., Owings Mills (MD), May 2000 [27] Rimland B. The use of secretin in Autism: some preliminary answers. Autism Res Rev Intl 1998;12(4):3 [28] Lewis LS. Special diets for special kids: understanding and implementing a gluten and casein free diet to aid in the treatment of autism and related developmental disorders. Future Horizons, Arlington (TX), 1998 [29] Dorfman K. Exploring the casein-free, gluten-free diet. New Developments;1(2):4 [30] Sacks BI, Buckley RF. Multi-nutrient formulas and other substances as therapies for Down syndrome: an overview. Down Syndrome News and Update 1(2):70-83, 1998 [31] Dwyer J. Fertile fields for fads and frauds: questionable nutritional therapies. NY State J Med, 1993:105-108 [32] Pruess JB, Fewell RR, Bennett FC. Vitamin therapy and children with Down syndrome: a review of research. Except Child,1989;55(4):336-341 [33] Luke A, Sutton M, Schoeller DA, Roizen NJ. Nutrient intake and obesity in prepubescent children with Down syndrome. J Am Diet Assoc,1996;96(12):1262-1267 [34] Reading CM. Down’s syndrome: nutritional interventions. Nutr Health,1984;3(1-2):91-111 [35] Turkel H, Nusbaum I. Medical Treatment of Down Syndrome and Genetic Diseases, 4th ed. Ubiotica, Southfield (MI), 1985 [36] Warner FJ, Stephens C. Metabolic supplementation for correction of raging free radicals in trisomy 21. Presentation at the International Down’s Conference. Madrid, Spain [37] Leichtman LG. Targeted nutritional intervention in the treatment of children and adults with Down syndrome. Presentation at the 1998 National Down Syndrome Congress, Meeting, Dallas, Texas, August 17, 1998 [38] Harrell RF, Capp RH, Davis DR, Peerless J, Ravitz LR. Can nutritional supplementation help mentally retarded children? an exploratory study. Proc Natl Acad Sci U S A,1981;78(1):574-578 [39] Weathers C. Effects of nutritional supplementation on IQ and certain other variables associated with Down syndrome. Am J Ment Defic,1983;88(2):214-217 [40] Bucci I, et al. Zinc sulfate supplementation improves thyroid function in hypozincemic Down children. Biol Trace Elem Res 1999;67(3):257-268 [41] Chandra RK, McBean LD. Zinc and immunity. Nutr, 1994;10(1) [42] Kadrabova J, et al. Changed serum trace element profile in Down’s syndrome. Biol Trace Elem Res 1996;64(3):201-206 [43] Anneren G, et al. Increase in serum concentrations of IgG2 and IgG4 by selenium supplementation in children with Down’s syndrome. Arch Dis Children, 1990;65:1353-1355 [44] Sherman AR. Zinc, copper and iron nutriture and immunity. J Nutr,1992;122:604-609 [45] Hopman E, et al. Nutritional aspects of children with Down syndrome. In Clinical Pearls 1999. ITServices, Sacramento, 1999:256 [46] Storm W. Prevalence and diagnostic significance of gliaden antibodies in children with Down’s syndrome. Eur J Ped, 1990;149:833-834 [47] Fuchtenbusch M, Karges W, Standl E, Dosch HM, Ziegler AG. Antibodies to bovine serum albumin in type 1 diabetes and other autoimmune disorders. Exp Clin Endocrinol Diabetes,1997;105(2):86-91 [48] Khalsa DS. Brain nutrients. Townsend Letter for Doctors and Patients, 2000; 205/206:132-133.
Underactive & Overactive
Thyroid, By: Judith A. DeCava, C.C.N., L.N.C. REFERENCES 1 Medical Tribune, 25 Jan 1996, p.2; J. Jayme, P. Ledenson, Trends in Endocrin Metab, Vol.5, 1994, pp.79-86; Health, Vol.10, No.7, Nov/Dec 1996, p.15; H. Bieler, Food is Your Best Medicine, NY: Ballantine, 1992, p.71; N. Walker, H. Santillo, Intuitive Eating, Prescott: Hohm Press, 1993, p.113; K. Bodner, Women’s Health Letter, Vol.VIII, No.2, Feb 1998, p.1; UC Berkeley Wellness Letter, Vol.12, Is.8, May 1996, pp.2-3; J. Mercola, Townsend Letter, May 1998, p.39. 2 P. Dranov, American Health, Vol.XIII, No.4, May 1994, pp.90-3; N. Kemp, Healthline, Vol.16, No.7, July 1997, pp.10-11; B. Kelley, Health, Vol.11, No.4, May/June 1997, pp.64-8; J. Lazarus, Lancet, Vol.349, No.9048, 1 Feb 1997, pp.339-43; Harvard Health Letter, Vol.24, No.3, Jan 1999, pp.6-7; R. Lindsay, A. Toft, Lancet, Vol.349, No.9049, 8 Feb 1997, pp.413-417; R. Utiger, Health News, Vol.4, No.11, 10 Sept 1998, p.3; H. Gharib, JAMA, Vol.275, No.7, 21 Feb 1996, p.513; Lancet, Vol.335, No.8701, 2 June 1990, p.1316; U. Kabodi, Arch Intern Med, Vol.153, 1993, pp.957-61; E. McLaren, et al, BMJ, Vol.315, 1997, p.1463; M. Centanni, et al, Eur J Endocrinol, Vol.136, 1997, pp.595-8; M. Fulop, Lancet, Vol.II for 1989, No.8662, 2 Sept 1989, pp.550-1; Amer J Natural Med, Vol.4, No.1, Jan/Feb 1997, p.25; Health News, Vol.4, No.10, 15 Aug 1998, p.6; Health News, 31 March 1998, p.7; Health Facts, Vol.22, No.4, April 1997, p.4. 3 C. Fuller, Thyroid Fndtn of America, Inc., brochure, June 1994; A. Freeman, Lancet, Vol.349, No.9057, 5 Apr 1997, pp.1023-4; NEJM, Vol.337, 1997, pp.1010-11; G. Clugston et al, Lancet, Vol.347, No.9007, 13 Apr 1996, p.1051; E. Gaitan, Diseases of the Thyroid, Totowa NJ: Humana Press, 1997, pp.331-348; J. Moss, Moss Nutr Peport, #148, Sept 1998, pp.1-8; W. Douglass, Second Opinion, Vol.1, No.8, Oct 1991, p.4; B. Berkowsky, Health Freedom News, Sept 1992, p.8; W. Rea, Chemical Sensitivity, Vol.3, Boca: CRC, 1996, pp.1654-8.
|
||